跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 290 条关于
“CICC”
全部
290
临床试验
252
药物
15
机构
3
资讯
20
去年
METiS Pharmaceuticals Plans $200 Million Hong Kong IPO to Advance AI-Driven Drug Development
4个月前
BeiGene and Revolution Medicines Forge Strategic Partnership to Bring Breakthrough Pancreatic Cancer Therapy to Asia
去年
Sino Biopharm Acquires LaNova Medicines for $950M, Expanding Innovative Drug Pipeline
9个月前
Syneron Bio Secures Nearly $100M Series A Funding for Macrocyclic Peptide Platform
去年
YolTech Therapeutics Secures $45 Million Series B Funding to Advance In Vivo Gene Editing Pipeline
2个月前
Jingze Bio Files Third HKEX IPO Application, Spotlighting Biosimilar Competition in China's Fertility and Ophthalmology Markets
去年
METiS Technologies Raises RMB 400 Million Series D to Advance AI-Driven Nanodelivery Platform
9个月前
RNA Drug Pioneer RiboBio Passes Hong Kong IPO Hearing with $2B+ Partnership Portfolio
2年前
Fecal Microbiota Transplant Enhances Immunotherapy Response in Metastatic Renal Cell Carcinoma
16天前
Cencora Launches Cell and Gene Therapy Enablement to Help Health Systems Build and Scale CGT Programs
第 1 页,共 2 页
上一页
下一页